These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7770125)

  • 1. Childhood stroke at three years of age with transient protein C deficiency, familial antiphospholipid antibodies and F. XII deficiency--a family study.
    Korte W; Otremba H; Lutz S; Flury R; Schmid L; Weissert M
    Neuropediatrics; 1994 Dec; 25(6):290-4. PubMed ID: 7770125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
    Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
    Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of factor XII in antiphospholipid antibody-positive patients with thrombotic events in the rheumatology clinic.
    Takeishi M; Mimori A; Nakajima K; Mimura T; Suzuki T
    Clin Rheumatol; 2003 Feb; 22(1):40-4. PubMed ID: 12605317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protean clinical presentation of antiphospholipid-protein antibodies (APA).
    Triplett DA
    Thromb Haemost; 1995 Jul; 74(1):329-37. PubMed ID: 8578480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies: lupus anticoagulants, anticardiolipin and antiphospholipid isotypes in patients with sickle cell disease.
    Nsiri B; Ghazouani E; Gritli N; Mazigh C; Bayoudh F; Messaoud T; Fattoum S; Machghoul S
    Hematol Cell Ther; 1998 Jun; 40(3):107-12. PubMed ID: 9698218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
    Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
    Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiphospholipid antibodies in asymptomatic pediatric patients].
    Aguilar Franco C; Lucía Cuesta J
    An Esp Pediatr; 2001 May; 54(5):444-9. PubMed ID: 11333473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lupus anticoagulant and antiphospholipid antibody values in a family with systemic lupus erythematosus].
    Alper G; Tavmergen EN; Ozsan H; Tavmergen E; Gümüsdis G; Onat T; Erlacin E
    Zentralbl Gynakol; 1992; 114(10):509-12. PubMed ID: 1414067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital deficiency of factor Xii and spontaenous venous thrombosis treated with urokinase].
    Cornudella R; Moreno JA; Aguado MJ; Ansó V; Revilla JM; Calvo MT; Gutiérrez M
    Sangre (Barc); 1995 Jun; 40(3):219-22. PubMed ID: 7570275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired protein C deficiency in a patient with primary antiphospholipid syndrome. Relationship to reactivity of anticardiolipin antibody with thrombomodulin.
    Ruiz-Arguelles GJ; Ruiz-Arguelles A; Deleze M; Alarcón-Segovia D
    J Rheumatol; 1989 Mar; 16(3):381-3. PubMed ID: 2542543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphospholipid antibodies in Turkish children with thrombosis.
    Tavil B; Ozyurek E; Gumruk F; Cetin M; Gurgey A
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):347-52. PubMed ID: 17473576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent foramen ovale and prothrombotic markers in young stroke patients.
    Belvís R; Santamaría A; Martí-Fàbregas J; Leta RG; Cocho D; Borrell M; Fontcuberta J; Martí-Vilalta JL
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):537-42. PubMed ID: 17762528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ischemic stroke with antiphospholipid antibody].
    Kitagawa Y; Ohkuma H; Tokuoka K
    Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
    Lackner KJ; von Landenberg C; Barlage S; Schmitz G
    Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiphospholipid syndrome: an evolving story.
    Robertson B; Greaves M
    Blood Rev; 2006 Jul; 20(4):201-12. PubMed ID: 16442679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.